Edwards, KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatric Infectious Disease Journal
2005; 24 (6 Suppl.): S104–108.
Winter, K, et al.
California pertussis epidemic, 2010. Journal of Pediatrics
2012; 161: 1091–1096.
de Greeff, SC, et al.
Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology (Cambridge, Mass)
2012; 23: 852–860.
Kwon, HJ, et al.
Infant pertussis and household transmission in Korea. Journal of Korean Medical Science
2012; 27: 1547–1551.
Forsyth, K, et al.
Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative. Southeast Asian Journal of Tropical Medicine and Public Health
2012; 43: 699–711.
Chiu, TF, et al.
Pertussis seroepidemiology in Taipei. Journal of the Formosan Medical Association
2000; 99: 224–228.
Hu, JJ, et al.
Survey of pertussis in patients with prolonged cough. Journal of Microbiology, Immunology, and Infection
2006; 39: 54–58.
Wilder-Smith, A, Ng, S, Earnest, A. Seroepidemiology of pertussis in the adult population of Singapore. Annals of the Academy of Medicine, Singapore
2006; 35: 780–782.
De, Serres G, et al.
Morbidity of pertussis in adolescents and adults. Journal of Infectious Diseases
2000; 182: 174–179.
Lin, PY, et al.
Bordetella pertussis infection in northern Taiwan, 1997–2001. Journal of Microbiology, Immunology, and Infection
2004; 37: 288–294.
van Hoek, AJ, et al.
The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales: a patient survey. PLoS ONE
2014; 9: e111807.
Versteegh, FG, et al.
Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiology and Infection
2005; 133: 737–748.
de Melker, HE, et al.
Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. Journal of Clinical Microbiology
2000; 38: 800–806.
Guiso, N, et al.
What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. European Journal of Clinical Microbiology & Infectious Diseases
2011; 30: 307–312.
Rabin, R, de Charro, F. EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine
2001; 33: 337–343.
Cherry, JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics
2005; 115: 1422–1427.
Senzilet, LD, et al.
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clinical Infectious Diseases
2001; 32: 1691–1697.
Riffelmann, M, et al.
Nucleic acid amplification tests for diagnosis of Bordetella infections. Journal of Clinical Microbiology
2005; 43: 4925–4929.
Forsyth, KD, et al.
Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine
2007; 25: 2634–2642.
Munoz, FM, et al.
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. Journal of the American Medical Association
2014; 311: 1760–1769.
Donegan, K, King, B, Bryan, P. Safety of pertussis vaccination in pregnant women in UK: observational study. British Medical Journal (Clinical Research Edition)
2014; 349: g4219.
Amirthalingam, G, et al.
Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet
2014; 384: 1521–1528.
International Labour Organization Regional Office for Asia and the Pacific. Global Wage Report 2014/15: Asia and the Pacific Supplement, December 2014.